Zimmer Biomet Holdings, Inc. (ZBH) |
| 94.08 2.74 (3%) 07-13 16:00 |
| Open: | 91.69 |
| High: | 95.48 |
| Low: | 91.3 |
| Volume: | 2,724,109 |
| Market Cap: | 18,201(M) |
| PE Ratio: | 11.09 |
| Exchange: | New York Stock Exchange |
| Industry: | Medical - Devices |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 111.52 |
| Resistance 1: | 95.48 |
| Pivot price: | 89.26 |
| Support 1: | 88.21 |
| Support 2: | 83.72 |
| 52w High: | 108.29 |
| 52w Low: | 79.12 |
Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. It operates through the following geographical segments: Americas, Europe Middle East and Africa, and Asia Pacific. The Americas segment consists of the U.S. and includes other North, Central and South American markets. The Europe Middle East and Africa segment includes France, Germany, Italy, Spain, and the United Kingdom. The Asia Pacific segment refers to the key markets such as Japan, China, Australia, New Zealand, Korea, Taiwan, India, Thailand, Singapore, Hong Kong, and Malaysia. The company was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.
| EPS | 3.860 |
| Book Value | 65.530 |
| PEG Ratio | 0.62 |
| Gross Profit | 30.497 |
| Profit Margin (%) | 9.05 |
| Operating Margin (%) | 19.69 |
| Return on Assets (ttm) | 4.1 |
| Return on Equity (ttm) | 6.1 |
Mon, 13 Jul 2026
Zimmer Biomet Holdings Inc (ZBH) Stock Up 3.0% and Still Underva - GuruFocus
Mon, 13 Jul 2026
Zimmer Biomet Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
Mon, 13 Jul 2026
Zimmer Biomet Rises as Investors Weigh Upcoming Earnings, Recent Product Activity, and Capital Return Support - Quiver Quantitative
Mon, 13 Jul 2026
Zimmer Biomet Announces Webcast and Conference Call of Second Quarter 2026 Financial Results - Investing News Network
Mon, 13 Jul 2026
Zimmer Biomet (ZBH) Q4 2025 earnings summary - Quartr
Mon, 13 Jul 2026
Zimmer Biomet to post Q2 2026 results before market, hold call at 8:30 a.m. ET - Stock Titan
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |